FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

CHAKOUTIS PETER M

2. Date of Event Requiring Statement (MM/DD/YYYY)
8/8/2019 

3. Issuer Name and Ticker or Trading Symbol

Biostage, Inc. [BSTG]

(Last)        (First)        (Middle)

C/O BIOSTAGE, INC., 84 OCTOBER HILL ROAD, SUITE 11

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Vice President of Finance /

(Street)

HOLLISTON, MA 07146      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)

 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)  (1)5/29/2028 Common Stock, par value $0.01 per share 38052 $2.72 D  
Stock Option (Right to Buy)  (2)8/8/2029 Common Stock, par value $0.01 per share 30000 $2.29 D  

Explanation of Responses:
(1) This stock option vests in four equal installments, including installments that vested on May 29, 2018 and May 29, 2019, those that vest on May 29, 2020, and May 29, 2021.
(2) This stock option vests in twelve consecutive equal quarterly installments commencing on November 8, 2019.

Remarks:
Exhibit List: Exhibit 24 - Limited Power of Attorney

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
CHAKOUTIS PETER M
C/O BIOSTAGE, INC.
84 OCTOBER HILL ROAD, SUITE 11
HOLLISTON, MA 07146


Vice President of Finance

Signatures
/s/ Chad J. Porter, by power of attorney8/19/2019
**Signature of Reporting PersonDate

Biostage (QB) (USOTC:BSTG)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Biostage (QB) Charts.
Biostage (QB) (USOTC:BSTG)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Biostage (QB) Charts.